Adipocyte ATP-binding cassette G1 promotes triglyceride storage, fat mass growth, and human obesity

Diabetes

Volumn 64, Issue 3, 2015, Pages 840-855

  Frisdal, Eric ^a,b,c   Le Lay, Soazig ^d   Hooton, Henri ^b,e   Poupel, Lucie ^c   Olivier, Maryline ^a,b   Alili, Rohia ^b,c,e   Plengpanich, Wanee ^a,f   Villard, Elise F ^a,b,c   Gilibert, Sophie ^a,b,c   Lhomme, Marie ^c   Superville, Alexandre ^a,b,c   Miftah Alkhair, Lobna ^a   Chapman, M John ^a,b   Dallinga Thie, Geesje M ^g   Venteclef, Nicolas ^b,c,e   Poitou, Christine ^b,c,e   Tordjman, Joan ^b,c,e   Lesnik, Philippe ^a,b,c   Kontush, Anatol ^a,b,c   Huby, Thierry ^a,b,c   Dugail, Isabelle ^b,c,e   Clement, Karine ^b,c,e   Guerin, Maryse ^a,b,c   Le Goff, Wilfried ^a,b,c   more..

^a Sorbonne Universités   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSERM   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; APOLIPOPROTEIN E; FAT DROPLET; LIPOPROTEIN LIPASE; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; ABC TRANSPORTER; ABCG1 PROTEIN, HUMAN; ABCG1 PROTEIN, MOUSE; LIPOPROTEIN; SMALL INTERFERING RNA;

ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC OBESITY; FAT MASS; FEMALE; GENE EXPRESSION; HAPLOTYPE; HUMAN; LIPID DIET; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN; 3T3 CELL LINE; ANIMAL; GENETICS; METABOLISM; MORBID OBESITY; PHYSIOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ADIPOSITY; ADULT; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; HUMANS; LIPOPROTEINS; MALE; MICE; OBESITY, MORBID; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, SMALL INTERFERING; TRIGLYCERIDES; WEIGHT GAIN;

EID: 84928208608     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0245     Document Type: Article

References (47)

1. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004;101:9774-9779
2. Kennedy MA, Barrera GC, Nakamura K, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005;1:121-131
3. Le Goff W, Dallinga-Thie GM. ABCG1: not as good as expected? Atherosclerosis 2011;219:393-394
4. Olivier M, Tanck MW, Out R, et al. Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formation. Arterioscler Thromb Vasc Biol 2012;32:2223-2231
5. Buchmann J, Meyer C, Neschen S, et al. Ablation of the cholesterol transporter adenosine triphosphate-binding cassette transporter G1 reduces adipose cell size and protects against diet-induced obesity. Endocrinology 2007;148:1561-1573
6. Umemoto T, Han CY, Mitra P, et al. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ Res 2013;112:1345-1354
7. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl) 2002;80:753-769
8. Gonzales AM, Orlando RA. Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr Metab (Lond) 2007;4:22
9. Spielmann N, Mutch DM, Rousseau F, et al. Cathepsin S genotypes are associated with Apo-A1 and HDL-cholesterol in lean and obese French populations. Clin Genet 2008;74:155-163
10. Ciangura C, Bouillot JL, Lloret-Linares C, et al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity (Silver Spring) 2010;18:760-765
11. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-553
12. Schuck S, Manninen A, Honsho M, Füllekrug J, Simons K. Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference. Proc Natl Acad Sci U S A 2004;101:4912-4917
13. Larrede S, Quinn CM, Jessup W, et al. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. Arterioscler Thromb Vasc Biol 2009;29:1930-1936
14. Milosavljevic D, Kontush A, Griglio S, Le Naour G, Thillet J, Chapman MJ. VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass. Biochim Biophys Acta 2003;1631:51-60
15. Kobayashi A, Takanezawa Y, Hirata T, et al. Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J Lipid Res 2006;47:1791-1802
16. Ivanova PT, Milne SB, Byrne MO, Xiang Y, Brown HA. Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. Methods Enzymol 2007;432:21-57
17. Camont L, Lhomme M, Rached F, et al. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler Thromb Vasc Biol 2013;33:2715-2723
18. Janes PW, Ley SC, Magee AI. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 1999;147:447-461
19. de Haan W, Bhattacharjee A, Ruddle P, Kang MH, Hayden MR. ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity. J Lipid Res 2014;55:516-523
20. Yvan-Charvet L, Ranalletta M, Wang N, et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 2007;117:3900-3908
21. Arimoto I, Saito H, Kawashima Y, Miyajima K, Handa T. Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions. J Lipid Res 1998;39:143-151
22. Saito H, Arimoto I, Tanaka M, et al. Inhibition of lipoprotein lipase activity by sphingomyelin: role of membrane surface structure. Biochim Biophys Acta 2000; 1486:312-320
23. Atger VM, de la Llera Moya M, Stoudt GW, Rodrigueza WV, Phillips MC, Rothblat GH. Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 1997;99:773-780
24. Jablin MS, Flasiński M, Dubey M, et al. Effects of beta-cyclodextrin on the structure of sphingomyelin/cholesterol model membranes. Biophys J 2010;99: 1475-1481
25. Ranalletta M, Wang N, Han S, Yvan-Charvet L, Welch C, Tall AR. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/-bone marrow. Arterioscler Thromb Vasc Biol 2006;26:2308-2315
26. Rensen PC, van Berkel TJ. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem 1996;271:14791-14799
27. Diabetes Atorvastin Lipid Intervention (DALI) Study Group. The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia. Diabetes Care 2001;24: 1335-1341
28. Villard EF, EI Khoury P, Frisdal E, et al. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels. Arterioscler Thromb Vasc Biol 2013;33:822-828
29. Le Lay S, Ferré P, Dugail I. Adipocyte cholesterol balance in obesity. Biochem Soc Trans 2004;32:103-106
30. Kennedy MA, Venkateswaran A, Tarr PT, et al. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem 2001; 276:39438-39447
31. Out R, Hoekstra M, Meurs I, et al. Total body ABCG1 expression protects against early atherosclerotic lesion development in mice. Arterioscler Thromb Vasc Biol 2007;27:594-599
32. Baldán A, Tarr P, Vales CS, et al. Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis. J Biol Chem 2006;281:29401-29410
33. Burgess B, Naus K, Chan J, et al. Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2008;28:1731-1737
34. Ntambi JM, Young-Cheul K. Adipocyte differentiation and gene expression. J Nutr 2000;130:3122S-3126S
35. Babaev VR, Fazio S, Gleaves LA, Carter KJ, Semenkovich CF, Linton MF. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest 1999;103:1697-1705
36. Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 2009;297:E271-E288
37. Radha V, Vimaleswaran KS, Ayyappa KA, Mohan V. Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population. Int J Obes (Lond) 2007;31:913-918
38. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord 1995;19:270-274
39. Weinstock PH, Levak-Frank S, Hudgins LC, et al. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A 1997;94:10261-10266
40. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995;270: 12953-12956
41. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 1996;15:5336-5348
42. Bouaboula M, Hilairet S, Marchand J, Fajas L, Le Fur G, Casellas P. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur J Pharmacol 2005;517:174-181
43. Seo JB, Moon HM, Kim WS, et al. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 2004;24:3430-3444
44. Tamori Y, Masugi J, Nishino N, Kasuga M. Role of peroxisome proliferatoractivated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 2002;51:2045-2055
45. Jones JR, Barrick C, Kim KA, et al. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 2005;102:6207-6212
46. He W, Barak Y, Hevener A, et al. Adipose-specific peroxisome proliferatoractivated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A 2003;100:15712-15717
47. Takahashi M, Yagyu H, Tazoe F, et al. Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity. J Lipid Res 2013;54:1124-1134